Leo Wealth’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
Leo Wealth's FTH Position: Q3 2024 in Review
Leo Wealth sold out of Faeth Therapeutics (FTH) in Q3 2024, closing a stake of 742 shares — an estimated $9.2K sold.
Leo Wealth first reported a position in FTH in Q4 2023 and held it in 3 quarters. The position peaked at $15.6K in Q1 2024. 19 funds tracked by Wall St. Rank hold FTH as of Q3 2024.
- Leo Wealth reported no remaining Faeth Therapeutics position as of Q3 2024 after selling out during the quarter.
- Leo Wealth sold 742 Faeth Therapeutics shares in Q3 2024, an estimated $9.2K.
- Leo Wealth first reported a position in Faeth Therapeutics in Q4 2023 and held it in 3 quarters.
- Leo Wealth's Faeth Therapeutics position peaked at $15.6K in Q1 2024.
- 19 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2024.
Based on Leo Wealth's 13F filing for Q3 2024, filed 21 Oct 2024.